Reckitt Benckiser Group (RB) Stock Rating Reaffirmed by JPMorgan Chase & Co.

JPMorgan Chase & Co. reaffirmed their overweight rating on shares of Reckitt Benckiser Group (LON:RB) in a report released on Thursday morning. JPMorgan Chase & Co. currently has a GBX 7,500 ($101.71) target price on the stock.

A number of other brokerages have also recently commented on RB. Whitman Howard restated a buy rating and issued a GBX 9,000 ($122.05) price target on shares of Reckitt Benckiser Group in a research report on Monday, October 16th. Credit Suisse Group reaffirmed an outperform rating and issued a GBX 7,700 ($104.42) price objective on shares of Reckitt Benckiser Group in a research note on Friday, October 13th. Morgan Stanley set a £100 ($135.61) price objective on Reckitt Benckiser Group and gave the company a buy rating in a research note on Wednesday, October 11th. Deutsche Bank reaffirmed a buy rating and issued a GBX 8,500 ($115.27) price objective on shares of Reckitt Benckiser Group in a research note on Thursday, October 12th. Finally, Kepler Capital Markets reaffirmed a hold rating and issued a GBX 7,300 ($99.00) price objective on shares of Reckitt Benckiser Group in a research note on Wednesday, October 18th. Two analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have assigned a buy rating to the company. Reckitt Benckiser Group presently has an average rating of Hold and an average price target of GBX 7,619.09 ($103.32).

Reckitt Benckiser Group (LON:RB) traded down GBX 31.67 ($0.43) during mid-day trading on Thursday, reaching GBX 6,881.33 ($93.32). The company’s stock had a trading volume of 504,572 shares, compared to its average volume of 1,090,000. The company has a market cap of $48,450.00 and a PE ratio of 2,301.45. Reckitt Benckiser Group has a 1 year low of GBX 6,299 ($85.42) and a 1 year high of GBX 8,110.43 ($109.99).

In related news, insider Adrian Nevil Hennah bought 2,285 shares of the business’s stock in a transaction that occurred on Wednesday, November 8th. The shares were bought at an average price of GBX 6,567 ($89.06) per share, with a total value of £150,055.95 ($203,493.29). Also, insider Christopher Sinclair bought 2,800 shares of the business’s stock in a transaction that occurred on Wednesday, November 1st. The shares were bought at an average cost of GBX 6,597 ($89.46) per share, for a total transaction of £184,716 ($250,496.34).

COPYRIGHT VIOLATION NOTICE: “Reckitt Benckiser Group (RB) Stock Rating Reaffirmed by JPMorgan Chase & Co.” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this story on another publication, it was illegally copied and republished in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://stocknewstimes.com/2018/01/22/reckitt-benckiser-group-rb-stock-rating-reaffirmed-by-jpmorgan-chase-co-2.html.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply